Reduction of Cancer-Induced Thrombocytosis as a Biomarker of Improved Outcomes in Advanced Gastric Cancer.

Kamil KonopkaPaulina FrączekMaciej LubaśAgnieszka M MicekŁukasz KwintaJoanna StrebPaweł PotockiPiotr J Wysocki

Published in: Journal of clinical medicine (2022)

Thrombocytosis reduction represents a novel, clinically important, prognostic factor for OS and PFS in patients with stage IV GC.

Keyphrases